about
Influenza A/H1N1 vaccine in patients treated by kidney transplant or dialysis: a cohort studyTCF7L2 polymorphism associates with new-onset diabetes after transplantation.Laparoscopic-Assisted Recipient Nephrectomy and Recipient Kidney Procurement during Orthotopic Living-Related Kidney Transplantation.Conversion to sirolimus for chronic renal allograft dysfunction: risk factors for graft loss and severe side effectsConversion from tacrolimus to cyclosporine A for new-onset diabetes after transplantation: a single-centre experience in renal transplanted patients and review of the literature.Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients.Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial.Characteristics of first urinary tract infection with fever in children: a prospective clinical and imaging study.Evolution of immunoglobulin and mannose binding protein levels after renal transplantation: association with infectious complications.Shipping donor kidneys within Eurotransplant: outcomes after renal transplantation in a single-centre cohort study.Combined introduction of anti-IL2 receptor antibodies, mycophenolic acid and tacrolimus: effect on malignancies after renal transplantation in a single-centre retrospective cohort study.Prospective randomized study of conversion from tacrolimus to cyclosporine A to improve glucose metabolism in patients with posttransplant diabetes mellitus after renal transplantation.Genetic forms of nephrotic syndrome: a single-center experience in BrusselsBalancing Immunosuppressive Efficacy and Prevention of Posttransplant Diabetes-A Question of Timing and Patient Selection.Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantationArteriovenous fistula closure after renal transplantation: a prospective study with 24-hour ambulatory blood pressure monitoringArteriovenous fistula after renal transplantation: utility, futility or threat?Thrombophilic factors in Stage V chronic kidney disease patients are largely corrected by renal transplantationImproving outcomes after renal transplantation starts well before surgery - the role of renal replacement modality
P50
Q30407134-04D8963B-C9C0-49D7-897D-193ABC45A02EQ33561720-589DA37B-88FB-48C8-86A7-C60C2EBBDC24Q36417600-BDC2EC57-2E02-4C83-955D-06BD2D3A366BQ36938848-C54FCE00-6B90-4808-88A5-9CFDE36A3D6DQ36986132-1D925D35-0EE9-45D1-BD56-10284E9A7DCCQ37211151-15EB027A-573D-4652-89E0-D33DED1B1CDFQ38497908-FE2EADB8-7758-4FAF-B3DB-1F2C96278506Q40327599-64E4A073-6A79-439B-8C41-A9849B6924F7Q44733015-220304CD-6328-4AE2-9A7D-EA450DA47418Q44814399-E9C0A4C1-85EB-426F-89B2-41ECA967A30BQ45889924-19CE6280-F9FA-411C-9AA6-AE37CC71BD00Q50029795-F75E7849-C465-4D8D-B1BB-560D8AF09972Q63461225-F25FA205-90B5-457D-B128-88C3BC145CE0Q64996237-93591629-9C61-4F81-A8E6-3D3F29D02E15Q79150730-6D3275BB-447C-4BCA-ADDB-E585DD219C7FQ80776299-24260381-A3B7-4B08-B78B-825777F02E13Q81491723-EC00F73D-C443-48D7-8B82-5358DDB88D73Q83341180-84F69BDC-B948-4514-B1FB-8C485EAB55A5Q91975575-1FAA1F80-16D7-4369-AF0D-530EAA1D46A4
P50
description
researcher ORCID ID = 0000-0002-6094-3233
@en
wetenschapper
@nl
name
Karl Martin Wissing
@ast
Karl Martin Wissing
@en
Karl Martin Wissing
@es
Karl Martin Wissing
@nl
type
label
Karl Martin Wissing
@ast
Karl Martin Wissing
@en
Karl Martin Wissing
@es
Karl Martin Wissing
@nl
prefLabel
Karl Martin Wissing
@ast
Karl Martin Wissing
@en
Karl Martin Wissing
@es
Karl Martin Wissing
@nl
P21
P31
P496
0000-0002-6094-3233